Chicago Equity Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$622K Sell
8,470
-22,275
-72% -$1.93M 0.06% 378
2019
Q4
$2.58M Sell
30,745
-19,770
-39% -$1.53M 0.15% 204
2019
Q3
$4.25M Buy
50,515
+38,505
+321% +$2.91M 0.2% 144
2019
Q2
$786K Sell
12,010
-23,855
-67% -$1.37M 0.04% 586
2019
Q1
$2.12M Buy
+35,865
New +$2.14M 0.08% 330

Other funds holding MEDP

Chicago Equity Partners's MEDP Position: Q1 2020 in Review

Chicago Equity Partners reduced its Medpace (MEDP) stake by 72% in Q1 2020, selling an estimated $1.93M and leaving 8,470 shares worth $622K. The position accounts for 0.06% of the portfolio, ranked #378.

Chicago Equity Partners first reported a position in MEDP in Q1 2019 and has held it in 5 quarters since. The position peaked at $4.25M in Q3 2019. 269 funds tracked by Wall St. Rank hold MEDP as of Q1 2020.

  • Chicago Equity Partners held 8,470 shares of Medpace worth $622K as of Q1 2020.
  • Chicago Equity Partners sold 22,275 Medpace shares in Q1 2020, an estimated $1.93M.
  • Medpace made up 0.06% of Chicago Equity Partners's portfolio in Q1 2020, its #378 holding.
  • Chicago Equity Partners first reported a position in Medpace in Q1 2019 and has held it in 5 quarters since.
  • Chicago Equity Partners's Medpace position peaked at $4.25M in Q3 2019.
  • 269 funds tracked by Wall St. Rank held Medpace as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.